• Lab-Grown Brain Models Could Bring ‘Clinical Trials in a Vial,’ Harvard Researcher Says

    Clinical Research NewsBrain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study.

    Oct 8, 2026

  • Lab-Grown Brain Models Could Bring ‘Clinical Trials in a Vial,’ Harvard Researcher Says

    Clinical Research News | Brain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study.

    Oct 8, 2026

  • The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality

    Clinical Research NewsToday, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model.

    Oct 6, 2026

  • The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality

    Clinical Research News | Today, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model.

    Oct 6, 2026